Latest United Kingdom News

Sigma Healthcare reports robust growth in Chemist Warehouse sales across Australia and internationally, announces a joint venture to enter the UK market, and secures a major distribution centre lease in New Zealand to support its expanding network.

4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

Duratec's joint venture with Ertech has clinched a $281 million contract to upgrade submarine infrastructure at HMAS Stirling, marking a major step in Australia's AUKUS defence preparations.

Genetic Signatures has locked in a 10-year supply deal with Denmark’s Hvidovre Hospital for its EasyScreen™ Pan-Enteric assay, marking a significant step in its European expansion. The agreement covers 28,000 tests in the first year with growth expected, leveraging the company’s proprietary 3base® technology to streamline complex gastrointestinal pathogen detection.

Red Sky Energy has secured full underwriting for its 2-for-3 non-renounceable rights issue to raise approximately AU$4.2 million, supported by sub-underwriting commitments from related parties. Concurrently, the company has initiated a cost reduction program including a 25% pay cut for senior management and staff reductions.

Macallum New Energy has progressed its seismic exploration in the North Perth Basin with the Barberton 3D survey underway and Condor 2D survey approved, while appointing Greenwood Capital Partners to enhance its UK and European market presence.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Bioxyne Ltd has secured a manufacturing agreement with global cannabis giant Aurora Cannabis, marking a major step in its international expansion of pharmaceutical-grade medicinal cannabis products.

Red Sky Energy is set to raise up to $5.2 million through a placement and rights issue to fund its participation in a Santos-operated drilling program in South Australia’s Innamincka Dome. The capital raise aims to accelerate near-term production and cash flow from existing and new wells.

Redivium Limited advances its recapitalisation efforts and project development despite ASX suspension, withdrawing its European Green Bond and exploring new UK site options.

Alcoa Corporation has updated its dividend notification for the quarter ending December 2025, clarifying currency exchange rates and payment methods for its shareholders.